An FDA approved AI solution based on a convolutional neural network was used to assess 8468 NCCTs. Data was collected from 29 different facilities. NCCTs were retrospectively processed through the AI solution and assigned a positive or negative for ICH allocation. Each report was analyzed by NLP software and assigned a positive or negative for ICH allocation per the radiologist’s interpretation. Cases that were discordant were assessed by 3 radiologists for ground truth.
Concordant cases included 288 double positives (AI+/Rad+) and 7950 double negatives (AI-/Rad-). 132 discordant cases included 100 scans positive by AI and negative per radiologist’s report (AI+/Rad-), and 32 scans negative by AI and positive by report (AI-/Rad+). AI demonstrated an accuracy of 98.8%, sensitivity of 93.6%, and a specificity of 99.1%. The radiologists detected 309 positive cases, and an additional 18 ICHs were detected by the AI solution, providing an added detection rate of 5.8%
The combined precision and accuracy of the AI-radiologist combination highlights the value of coupling a high sensitivity screening test (AI) with a higher specificity validation test (radiologist).
Aidoc experts, customers and industry leaders share the latest in AI benefits and adoption.
Explore how clinical AI can transform your health system with insights rooted in real-world experiences.
Learn how to go beyond the algorithm to develop a scalable AI strategy and implementation plan.
Explore how Aidoc can help increase hospital efficiency, improve outcomes and demonstrate ROI.
